Prognostic Factors for Relapse in Stage I Testicular Seminoma Treated With Surveillance-Reference-Cited by-同舟云学术

Prognostic Factors for Relapse in Stage I Testicular Seminoma Treated With Surveillance

Published:1997-05 Issue:5 Volume:157 Page:1705-1710
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Warde P.¹,Gospodarowicz M.K.¹,Banerjee D.¹,Panzarella T.¹,Sugar L.¹,Catton C.N.¹,Sturgeon J.F.G.¹,Moore M.¹,Jewett M.A.S.¹

Affiliation:

1. From the Departments of Radiation Oncology, Medicine and Pathology, and Division of Urology, University of Toronto and Toronto Hospital, and Departments of Radiation Oncology, Medical Oncology, Surgical Oncology, Biostatistics and Oncologic Pathology, Princess Margaret Hospital, Toronto, Ontario, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Consensus statement on the investigation and management of testicular seminoma;Thomas;Prog. Clin. Biol. Res.,1990

2. Radiotherapy for stage I seminoma testis: results of treatment and complications;Hamilton;Radiother. Oncol.,1986

3. Recovery from aspermia induced by low-dose radiation in seminoma patients;Hahn;Cancer,1982

4. The effects of abdominal irradiation for seminoma of the testis on gastrointestinal function;Yeoh;J. Gastro-Enterol. Hepatol.,1995

5. Incidence of second primary cancer following testicular cancer;Moller;Eur. J. Cancer,1993

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifocality in Testicular Cancer: Clinicopathological Correlations and Prognostic Implications;Life;2024-02-16

2. Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study;Journal of Clinical Oncology;2024-01-01

3. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office;European Urology Oncology;2023-11

4. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma;Pathology - Research and Practice;2023-02

5. Biomarkers of disease recurrence in stage I testicular germ cell tumours;Nature Reviews Urology;2022-08-26